<DOC>
	<DOC>NCT02295800</DOC>
	<brief_summary>The study design includes an observational prospective cohort of HIV-positive pregnant/postpartum women and their infants enrolled during antenatal clinics (or immediately postpartum) from prevention of mother-to-child transmission (PMTCT) programs and followed until the infants reach the age of 18 - 24 months and semi-structure interviews with a sub-set of these women. A second study component involves semi-structured interviews with health care workers (HCW) involved in the PMTCT programs and yearly facility surveys at the selected study facilities.</brief_summary>
	<brief_title>The Kabeho Study: Kigali Antiretroviral and Breastfeeding Assessment for the Elimination of HIV</brief_title>
	<detailed_description />
	<criteria>Documented HIV infection Pregnant, in the last trimester of pregnancy or within two weeks postdelivery. Participation in the PMTCT program during antenatal care at one of the study sites Planning on remaining in the Kigali area after delivery Able and willing to give informed consent for study participation for herself and her infant(s). If a pregnant woman is less than 18 years of age and still living with her parents, informed consent will also be required from one of her parents Women not willing to provide informed consent to participate</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>HIV</keyword>
	<keyword>PMTCT</keyword>
	<keyword>Antenatal Care</keyword>
</DOC>